✦ LIBER ✦

5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration

✍ Scribed by Jan Buter; Harm A. M. Sinnige; Dirk Th. Sleijfer; Elisabeth G. E. de Vries; Pax H. B. Willemse; Winette T. A. van der Graaf; René C. J. Verschueren; Nanno H. Mulder

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 420 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950301)75:5<1072::aid-cncr2820750504>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Fluorouracil/leucovorin/interferon alp

5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer

✍ Peter B. Vermeulen; Luc Y. Dirix; Gino Pelgrims; Allan T. van Oosterom; Nanno H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 2 views

Bimonthly high dose leucovorin and 5-flu

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma

✍ Christophe Tournigand; Christophe Louvet; Aimery de Gramont; Elisabeth Lucchi; J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

disease progression. IFN was administered subcutaneously three times weekly at for the Groupe d'Etude et de a dose of 3 MU (body surface area [BSA] õ 1.75 m 2 ) or 4.5 MU (BSA ¢ 1.75 m 2 ). Recherche sur les Cancers de RESULTS. World Health Organization toxicity Grade 3-4 occurred in 21 patients l'O

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views